Expertise: Oncology & Hematology 91 results

Clinical Development

Celebrating World Cancer Day: An Interview with Leading Oncology Experts

Every year on February 4th, the world comes together to recognize World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC). This day unites individuals, communities, and organizations in the fight against cancer while raising awareness and promoting actions to reduce its global impact. For 2025, the theme “United by…

Clinical Development

Bringing an Oncology Asset to Market: In-House vs Outsource?

During the multifaceted journey of bringing a promising therapeutic to market, sponsors are faced with a critical choice—whether to manage asset development in-house or to outsource to a clinical research organization (CRO) partner. This decision can influence timelines, costs, control over the development process, and the likelihood of success. Understanding the pros and cons of…

Oncology & Hematology

What is Logic-Gating and Why Does It Matter in CAR-T Therapy? 

Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment landscape for certain hematological malignancies, offering hope where conventional therapies have been exhausted. By reprogramming a patient’s own T-cells to recognize and attack cancer cells, CAR-T therapy embodies the promise of personalized medicine. However, challenges such as severe immune-related toxicities, antigen escape, microenvironment suppression, and…